2014-04-24 09:23:02 - India Pharmaceuticals and Healthcare Report Q3 2013 - a new market research report on companiesandmarkets.com
Despite slowing growth in the Indian pharmaceutical market in the first four months of 2013, top domestic firms continued to see strong double-digit growth in the latest quarter, outperforming multinational pharmaceutical firms. We maintain that the Indian government´s cost concerns will continue to hinder revenue growth for multinational pharmaceutical firms, benefiting the domestic industry. In foreign markets, Indian pharmaceutical firms will have to be more vigilant with manufacturing practices or risk suffering losses due to drug recalls.
Headline Expenditure Projections
Pharmaceuticals: INR840bn (US$15.7bn) in 2012 to INR926.1bn (US$17.0bn) in 2013; +10.3% in local currency terms and +8.3% in US dollar terms. Forecast slightly downgraded from Q213 due to slower growth in the first four months of 2013.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.